sNN-0031

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamesNN-0031
Drug Alias Namerh PDGF-BBsNN-0031
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionPlatelet-derived growth factor receptor agonistsDopamine transporter agonists
TargetsDopamine transporterPlatelet-derived growth factor receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNewron Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNewron Pharmaceutical
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A